LXEO
#3391
Lexeo Therapeutics, Inc. - Common Stock
3.0 4 USD
-0.06%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-5.88%
Variación mensual
-29.47%
Variación en los últimos 6 meses
-52.87%
Cambio anual
-62.33%
Cierres anteriores
3.2 3
Open
3.2 2
Mínimo
3.0 4
Máximo
3.2 2
Financials
- Market Capitalization 249.42 M
- Employee 59
- Founded 2017
- CEO N/A
- Website www.lexeotx.com
- Headquarter New York, United States
- FIGI BBG00YB1C8M5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3380 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.13 USD | -2.29% | -12.70% | -7.39% | +54.35% | 255.22 M USD | ||
| 3389 |  IMRX Immuneering Corporation - Class A Common Stock | 3.86 USD | -2.03% | -4.93% | -9.81% | -36.51% | 249.73 M USD | ||
| 3392 |  ACIU AC Immune SA - Common Stock | 2.45 USD | -2.00% | -9.93% | -10.26% | -28.57% | 249.27 M USD | ||
| 3418 |  LCTX Lineage Cell Therapeutics, Inc. Common Stock | 0.95 USD | -4.04% | +1.06% | -6.86% | -44.67% | 240.26 M USD |